NEW YORK Johnson & Johnson has vowed to appeal a $4.7 billion verdict awarded to 22 women who claim asbestos-contaminated talc in the company's products gave them ovarian cancer by arguing the plaintiffs' science was flawed and the case should not have been heard in Missouri. | Video
- Iowa, Illinois investigating infections linked to McDonald's salad |
- FDA flags sale of recalled Kellogg's Honey Smacks cereal
- CMS proposes change in the drug payment amount under Medicare Part B
- Indivior wins preliminary injunction against generic rival
- Why Canadian insurers are wary of covering medical marijuana
SHANGHAI China's new medical insurance regulator will begin negotiations with domestic and overseas pharmaceutical companies to lower prices of cancer drugs in a bid to cut the financial burden on patients, state news agency Xinhua said on Saturday.
A U.S. appeals court on Friday ruled invalid patents owned by Jazz Pharmaceuticals PLC covering its narcolepsy drug Xyrem, giving Amneal Pharmaceuticals Inc a boost in its effort to launch a generic version of the medicine.
(Reuters Health) - Today's moms-to-be are more likely than women from their mothers' generation to become depressed while pregnant, a study suggests.
NEW YORK (Reuters Health) - There is a new epidemic of hepatitis C, HIV, and other infections within the opioid abuse epidemic, according to participants in a National Academies of Sciences, Engineering, and Medicine workshop.